292 related articles for article (PubMed ID: 11465557)
1. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
[TBL] [Abstract][Full Text] [Related]
2. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
Hayashi Y; Guo TZ; Maze M
Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
[TBL] [Abstract][Full Text] [Related]
3. Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats.
Hayashi Y; Guo TZ; Maze M
Anesth Analg; 1996 Sep; 83(3):606-10. PubMed ID: 8780290
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nitric oxide metabolism enhances the hypnotic-anesthetic action of the alpha2-adrenoceptor agonist dexmedetomidine in vivo.
Tonner PH; Scholz J; Schlamp N; Schulte am Esch J
J Neurosurg Anesthesiol; 1999 Jan; 11(1):37-41. PubMed ID: 9890384
[TBL] [Abstract][Full Text] [Related]
5. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
[TBL] [Abstract][Full Text] [Related]
6. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.
Nelson LE; Lu J; Guo T; Saper CB; Franks NP; Maze M
Anesthesiology; 2003 Feb; 98(2):428-36. PubMed ID: 12552203
[TBL] [Abstract][Full Text] [Related]
7. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
[TBL] [Abstract][Full Text] [Related]
8. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats.
Joó G; Horvath G; Klimscha W; Kekesi G; Dobos I; Szikszay M; Benedek G
Anesthesiology; 2000 Jul; 93(1):231-41. PubMed ID: 10861167
[TBL] [Abstract][Full Text] [Related]
9. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
10. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of alpha 2-adrenergic agonists in the rat.
Hayashi Y; Rabin BC; Guo TZ; Maze M
Anesthesiology; 1995 Oct; 83(4):816-22. PubMed ID: 7574062
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide, adenosine, N-methyl-D-aspartate receptors, and neuronal activation in hypoxia-induced pial arteriolar dilation in rats.
Pelligrino DA; Wang Q; Koenig HM; Albrecht RF
Brain Res; 1995 Dec; 704(1):61-70. PubMed ID: 8750962
[TBL] [Abstract][Full Text] [Related]
12. The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists.
Vulliemoz Y; Whittington RA; Virag L
Brain Res; 1999 Dec; 849(1-2):169-74. PubMed ID: 10592299
[TBL] [Abstract][Full Text] [Related]
13. KEA-1010, a ketamine ester analogue, retains analgesic and sedative potency but is devoid of Psychomimetic effects.
Harvey M; Sleigh J; Voss L; Bickerdike M; Dimitrov I; Denny W
BMC Pharmacol Toxicol; 2019 Dec; 20(1):85. PubMed ID: 31856925
[TBL] [Abstract][Full Text] [Related]
14. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices.
Lue WM; Su MT; Lin WB; Tao PL
Eur J Pharmacol; 1999 Oct; 383(2):129-35. PubMed ID: 10585526
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
[TBL] [Abstract][Full Text] [Related]
16. Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice.
Thorat SN; Bhargava HN
Brain Res; 1994 Dec; 667(1):77-82. PubMed ID: 7534610
[TBL] [Abstract][Full Text] [Related]
17. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
18. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
19. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
20. The dissociation of sedative from spinal antinociceptive effects following administration of a novel alpha-2-adrenoceptor agonist, MPV-2426, in the locus coeruleus in the rat.
Xu M; Wei H; Kontinen VK; Kalso E; Pertovaara A
Acta Anaesthesiol Scand; 2000 Jul; 44(6):648-55. PubMed ID: 10903011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
